Latest Dilution News

Carnaby Resources, Hammer Metals' JV partner, has announced a maiden high-grade copper-gold resource at South Hope, part of the Greater Duchess Project, which now totals 29.2Mt at 1.3% copper and 0.2 g/t gold.

Highfield Resources has secured a A$10 million investment from existing strategic shareholders, extending its financial runway through early 2027 while awaiting a critical Spanish Supreme Court ruling on its Goyo mining permit appeal.

AUB Group Limited has announced the acquisition of a 95.9% stake in UK-based PIHL Holdings Limited (Prestige) for AUD 432 million, significantly expanding its UK retail insurance broking footprint. To fund this strategic move, AUB is launching a fully underwritten AUD 400 million institutional placement alongside a share purchase plan.

OzAurum Resources reports robust, shallow high-grade gold results from its James Stage 1 open pit drilling, reinforcing confidence in near-term development and hinting at significant expansion potential.

LinQ Minerals has raised A$15.4 million through a strongly supported institutional placement to accelerate drilling at its Gilmore Gold-Copper Project. The capital injection comes with attaching options and sets the stage for intensified exploration activity.

Iltani Resources has announced a maiden JORC Mineral Resource Estimate for its Orient East Silver-Indium deposit, alongside a significant $8 million investment from Queensland Investment Corporation’s Critical Minerals Fund to accelerate project development.

Nexsen Limited has won a $500,000 non-dilutive grant to extend its rapid Group B Streptococcus diagnostic technology into neonatal care, opening a significant new market opportunity.

Heavy Minerals Limited has formalised a binding agreement with Hillgrove Resources to develop a pioneering garnet extraction project at the Kanmantoo Copper Mine, aiming to start production in late 2026.

1414 Degrees has returned to trading on the ASX following a significant capital raise involving 44 million new shares issued to US institutional investor Lind Global Fund II. This move marks a key step in the company’s ongoing funding strategy to support its renewable energy technologies.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

Nova Minerals has secured US$43.4 million in non-dilutive funding from the U.S. Department of War to fully fund its domestic antimony supply chain development in Alaska, while also progressing its vast Estelle gold project with promising drilling results.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.